London Region Pharmaceutical Services Regulations Committee

Size: px

Start display at page:

Download "London Region Pharmaceutical Services Regulations Committee"

Annabelle Cameron
5 years ago
Views:

1 London Region Pharmaceutical Services Regulations Committee 27 October 2016 Part 2, London Area agenda item number 4A Decision report on an application for inclusion in the pharmaceutical list no significant change relocation application to another HWB s area Newham HWBB Name of applicant Fitness to practice Address of current premises Address of proposed premises Status of location Relevant regulations and guidance Laville Ltd Not applicable, already included in respect of other premises. 62A Leytonstone Road, Stratford, London, E15 1SQ 155 Leytonstone Road, Stratford, London, E15 1LH Non controlled locality Regulations 24 relocations that do not result in significant change to pharmaceutical services provision Regulation 31 refusal: same or adjacent premises DH market entry guidance chapter 10. Interested parties notified of the application 1 Boots HO covering branches at: 813 High Road, E11 1HQ Lower Ground Floor, The Arcade Westfield, Stratford City, E20 1EH The Mall, The Stratford Centre 15 1XD Acheason 273 High Road, E11 4HH ASDA Instore Pharmacy 1 Leyton Mills, E10 5NH Bower Chemists 340 Grove Green Road, E11 4EA Burns Chemist High Road, E11 3HR Granshaws Chemist 137 Cann Hall Road, E11 3NJ Langthorne Pharmacy Langthorne HC, 13 Langthorn Rd, E11 4HX Leyton Orient Pharmacy 2 nd Floor Matchroom Stadium, Oliver Road, E10 5NF Marijak ltd 354 High Road, E10 6QE Meraj Pharmacy 471 High Road, E10 5EL Representations submitted not sufficient for appeal rights. 1 List all interested persons who were notified of the application and indicate whether they submitted representations. 1

2 Safedale Ltd 98 Francis Road, E10 6PP Safedale Ltd 124 Langthorne Road, E11 4HS Safedale Ltd 144 High Road, E15 1UA Woodstone Pharmacy 851 High Road, E11 1HH Akro 404 Katherine Road, E7 8NP Britannia Pharmacy 6 church Street, E15 3HX Cartwights Chemist 67 Leytonstone Road, E15 1JA Crailmay Pharmacy 70 Green Street, E7 8JG Day Lewis Pharmacy 79 Upton Lane, E7 9PB Kalhan Limited 75 Plashet Road, E13 0QA LRM Dispensing Chemists 229 Plashet Road, E7 0EL Malchem Pharmacy 63 Woodgrange Road, E7 0EL Mansons Chemists 15 Woodgrange Road, E7 8BA Mayors Chemist 45 Upton Lane, E7 9PA Mayors Chemist 127 The Grove, E15 1EN Medina Pharmacy 161 Plaistow Road, E15 3ET Osbon Pharmacy 54 The Mall, E15 1XE Pharmaram Pharmacy 169 Plashet Grove, E6 1BX Rohpharm Ltd 212 Plaistow Road, E13 0AL Salus Pharmacy 42 Liberty Bridge Road, E20 1AS Shan Chemist 453 Romford Road, E7 8AB Sherman Pharmacy Woodgrange Road, E7 0EW Vicarage Pharmacy Vicarage Lane Health Centre, E15 4ES Wagpharm Chemist 8 Mitre Road, E15 3JF Woodgrange Pharmacy Woodgrange Road, E7 0EW Woodside Pharmacy Beacontree, 633 High Road, E11 4RD Mrs Karen Cooper Londonwide LMC s Tavistock House North Tavistock Square WC1H 9HX 2

3 Day Lewis Ltd 2 Peterwood Way Croydon CR0 4UQ Boots UK Ltd Asst NHS Contracts Manager D90 East F08, Nottingham NG90 1BS Mr Hemant Patel (NE London LPC) 1 Spurgate, Hutton, Brentwood CM13 2LA Waltham Forest Health & Wellbeing Board Town Hall, Forest Road, Walthamstow E17 4JF Healthwatch Waltham Forest Unit 15 Alpha Business Centre 60 South Grove, Walthamstow E17 7NX Newham Health & Wellbeing Board Newham Dockside, 1000 Dockside London E16 2QU Healthwatch Newham The Resource Centre, 200 Chargeable Lane, London E13 8DW NHS England Comments The PSRC have been provided with copies of all comments received for this application and in making a determination will have considered these even if they have not been expressly referred to in this report. The recommendation is that there is enough information within the papers to decide the application without an oral hearing. Regulation 31 The proposed pharmacy is not on the same site or adjacent to any other pharmacy, therefore this regulation is not engaged. Consider the impact of decision on those with protected characteristics under the Equalities Act 2010 and is this in accordance with NHS England s Public Sector Equality Duty. Consider impact of decision on NHS England s duty on health inequality. Regulation 24(1) criteria a) for the patient groups that are accustomed to accessing pharmaceutical services at the existing premises, the location of the new premises is not significantly less accessible; There is no information within the application or comments regarding any impact on this group. The recommendation is that there would be no impact. Applicant Patient groups that use the pharmacy are: Patients registered with local surgeries: the three largest patient groups comprise those patients registered with Leytonstone MC, 157 Leytonstone Rd, Thatched House MC, 136 High Road and Stratford HC, The Grove. Local Residents Patients registered with local surgeries but access pharmaceutical services independent from general medical services. Elderly & Disabled patients Overlap between the above groups. For all of the above groups the location of the new premises is not 3

4 significantly less accessible for the following reasons: Both premises are located on Leytonstone Rd, it takes 2 minutes by foot to walk between the two sites. There are no barriers to movement between the two sites nor are there any geographical barriers which will impede access to the new site. For those walking between the two sites, the pavements are flat, welllit and well maintained. The pavements also have dropped curbs and there is a designated pedestrian crossing point. This is beneficial for the elderly and disabled. For those accessing the site by car there will be no difference as they will be able to use the same car park. The majority of prescriptions dispensed originate from the practices detailed above. The proposed site is close to the existing site. Therefore the patient group who are registered patients of these surgeries and who have visited their GP and need to have a prescription dispensed, access to pharmaceutical services should be the same. NHS England comments/observations None of the parties notified have made any comments with the exception of Boots who have asked to be kept informed of the outcome of the application, but have no objections to the relocation as patient groups have been defined and the distance is short. The distance between the two sites is approx. 110 metres, and whilst the proposed site is on the opposite side of the road to the current site, there is a pedestrian crossing nearby. The walking distance between these two sites is only a few minutes and should not be an issue for patients. (b) in the opinion of the NHSCB, granting the application would not result in a significant change to the arrangements that are in place for the provision of local pharmaceutical services or of pharmaceutical services other than those provided by a person on a dispensing doctor list (i) in any part of the area of HWB1, or (ii) in a controlled locality in the area of a neighbouring HWB, where that controlled The PSRC have determined that the patients would not find this new site significantly less accessible. NHS England comments/observations The distance is short between these two premises. There is no evidence that the relocation would cause any changes to the arrangements in place for the provision of pharmaceutical services. The PSRC have determined that the move would not result in a change to the arrangements that are in place for the provision of local pharmaceutical services or pharmaceutical services. 4

5 locality is within 1.6 kilometres of the premises to which the applicant is seeking to relocate; (c) the NHSCB is satisfied that granting the application would not cause significant detriment to proper planning in respect of the provision of pharmaceutical services in the area of HWB1; (d) the services the applicant undertakes to provide at the new premises are the same as the services the applicant has been providing at the existing premises (whether or not, in the case of enhanced services, the NHSCB chooses to commission them); and (e) the provision of pharmaceutical services will not be interrupted (except for such period as the NHSCB may for good cause allow). Decision The PSRC have determined that granting this application would not cause detriment to proper planning. The applicant will provide the same services at the new location as at the existing location. The hours of the pharmacy will also be the same for the new premises as for the current one. There will be no interruption of services except for any period that NHS England Agrees. The PSRC have determined that there is enough information within the papers to decide the application without an oral hearing. There are no pharmacies within close proximity of the proposed site, therefore regulation 31 does not apply. Regulation 24(1)a the new premises are not significantly less accessible for patients. Regulation 24(1)b this move would not result in a change to the arrangements that are in place for the provision of local pharmaceutical services or pharmaceutical services Regulation 24(1)c - this application would not cause detriment to proper planning. Regulation 24(1)d the same services and hours are planned for the new premises. Regulation 24(1)e there will be no interruption of services The PSRC have determined that the application fits the criteria for regulation 24 and is therefore approved. 5

1 A summary of the application, decision, appeal and representations and observations are attached at Annex A.

1 A summary of the application, decision, appeal and representations and observations are attached at Annex A. REF: SHA/18077 APPEAL AGAINST LONDON AREA TEAM, NHS COMMISSIONING BOARD ("NHS ENGLAND") DECISION TO REFUSE AN APPLICATION BY TAYZANA LIMITED FOR A RELOCATION THAT DOES NOT RESULT IN A SIGNIFICANT CHANGE